Intestinal fat does not inhibit gastric function through a hormonal somatostatin mechanism in dogs

Kevin C K Lloyd, V. Maxwell, G. Ohning, J. H. Walsh

Research output: Contribution to journalArticlepeer-review

12 Scopus citations


In awake dogs with chronic gastric, duodenal, and jejunal fistulas, F(ab)1 fragments of somatostatin monoclonal antibody (mAb S607) were administered intravenously (IV) to test the hypothesis that intraintestinal lipid inhibits peptone-stimulated gastric acid secretion and emptying by a hormonal somatostatin mechanism. Plasma somatostatin was increased significantly by duodenal and jejunal perfusion with 20% lipid. Somatostatin administered IV caused dose-dependent inhibition of meal-stimulated gastric acid secretion and gastric emptying similar to that seen after intestinal perfusion with lipid. Administration of mAb S607 F(ab)1 fragments significantly reversed somatostatin (400 pmol · kg-1 · h-1, IV)-induced inhibition of peptonestimulated acid output and gastric emptying. Acid output inhibited by intraduodenal lipid was reversed partially after F(ab)1 administration, but the inhibitory effect of intrajejunal lipid was not altered. Inhibition of acid secretion by IV somatostatin and by intraintestinal fat was not caused by a decrease in circulating gastrin concentrations. Gastric emptying delayed by intraintestinal lipid was unaffected by antibody administration. Somatostatin does not appear to be a major hormonal mediator of intestinal fat-induced inhibition of gastric acid secretion or delayed gastric emptying in dogs.

Original languageEnglish (US)
Pages (from-to)1221-1228
Number of pages8
Issue number4
StatePublished - 1992

ASJC Scopus subject areas

  • Gastroenterology


Dive into the research topics of 'Intestinal fat does not inhibit gastric function through a hormonal somatostatin mechanism in dogs'. Together they form a unique fingerprint.

Cite this